Medical Technology

@xconomy.com 4 years ago

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

@xconomy.com 5 years ago

Laurie Glimcher To Headline Xconomy Keynote Series in Boston in September

@xconomy.com 5 years ago

FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take

@xconomy.com 5 years ago

RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug

@xconomy.com 5 years ago

Digital Tools, Online Community & More: Patient Partnership Award Finalists

@xconomy.com 5 years ago

Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug

@xconomy.com 5 years ago

Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision

@xconomy.com 5 years ago

In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine

@xconomy.com 6 years ago

Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M